Hepatic artery embolization for neuroendocrine tumors: Postprocedural management and complications

Oncologist

Volumn 17, Issue 5, 2012, Pages 725-731

  Lewis, Mark A ^a   Jaramillo, Sylvia ^a   Roberts, Lewis ^b   Fleming, Chad J ^a   Rubin, Joseph ^a   Grothey, Axel ^a  

^a Mayo Clinic College of Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Embolization; Liver metastasis; Neuroendocrine; Practice improvement

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; INFUSION FLUID; MORPHINE; OCTREOTIDE;

ADULT; AGED; ANALGESIA; ARTICLE; ARTIFICIAL EMBOLISM; BACTEREMIA; BODY TEMPERATURE; CARCINOID; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FEVER; GLOMERULUS FILTRATION RATE; HEPATIC ARTERY; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; KIDNEY FUNCTION; LENGTH OF STAY; LIVER ABSCESS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; RETROSPECTIVE STUDIES;

EID: 84861591919     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0372     Document Type: Article

References (26)

1. Klimstra DS, Modlin IR, Coppola D et al. The pathologic classification of neuroendocrine tumors: A review of nomenclature, grading, and staging systems. Pancreas 2010:39:707-712.
2. Rindi G, Klôppel G, Couvelard A et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: A consensus proposal including a grading system. Virchows Arch 2007;451:757-762.
3. Rindi G, Kloppel G, Alhman H et al. TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system. Virchows Arch 2006;449: 395-401.
4. Moertel CO. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987;5: 1502-1522.
5. Ho AS, Picus J, Darcy MD et al. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am J Roentgenol 2007;188:1201-1207.
6. Norton JA, Kerlan RK. Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: A commentary. Cancer J2003;9:241-243.
7. Strosberg JR, Choi J, Cantor AB et al. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control 2006;13:72-78.
8. Delaunoit T, Rubin J, Neczyporenko F et al. Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors. Mayo Clin Proc 2005; 80:502-506.
9. Eriksson BK, Larsson EG, Skogseid BM et al. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 1998;83:2293-2301
10. Atwell TD, Charboneau JW, Que FG et al. Treatment of neuroendocrine cancer metastatic to the liver: The role of ablative techniques. Cardiovasc Intervent Radiol 2005;28:409-421.
11. Reidy DL, Schwartz JD. Therapy for unresectable hepatocellular carcinoma: Review of the randomized clinical trials-I: Hepatic arterial embolization and embolization-based therapies in unresectable hepato cellular carcinoma. Anticancer Drugs 2004;15:427-437.
12. Salman HS, Cynamon J, Jagust M, et al. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer 2002;2: 173-179.
13. Hunt TM, Flowerdew AD, Birch SJ et al. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg 1990;77:779-782.
14. Lewis MA, Hubbard J. Multimodal liver-directed management of neuroendocrine hepatic metastases. Int J Hepatol 2011:452343.
15. Management of cancer pain guideline overview. Agency for Health Care Policy and Research Rockville, Maryland. J Nat Med Assoc 1994;86:571-573, 634.
16. Hurst RT, Prasad A, Askew JW 3rd et al. Takotsubo cardiomyopathy: A unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging 2010;3:641-649.
17. McCarthy P, Adam A, Jackson J, et al. Computed tomography demonstration of portal venous gas after hepatic artery embolization. Br J Radiol 1990;63:647-648.
18. Berger DH, Carrasco CH, Hohn DC et al. Hepatic artery chemoembolization or embolization fox primary and metastatic liver tumors: Post-treatment management and complications. J Surg Oncol 1995; 60:116-121.
19. Therasse E, Breittmayer F, Roche A et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology 1993;189:541-547.
20. Kirchhoff T, Chavan A, Galanski M. Chemoembo lization of hepatic metastases from intestinal neuroendocrine tumours. Eur J Gastroenterol Hepatol 2000;12: 141-143.
21. Meij V, Zuetenhorst JM, van Hillegersberg R et al. Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol 2005;3:75.
22. Slomka M, Radwan P. The evaluation of clinical results of hepatic artery embolization. Mater Med Pol 1992;24:193-195.
23. Gupta S, Yao JC, Ahrar K et al. Hepatic artery embolization and chemoembolization for treatment of pa tients with metastatic carcinoid tumors: The M.D. Anderson experience. Cancer J 2003;9:261-267.
24. Drougas JG, Anthony LB, Blair TK et al. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 1998;175:408-412.
25. Thornton RH, Covey A, Petre EN et al. A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years. Cancer 2009;115:5000-5006.
26. Barnett KT, Malafa MP. Complications of hepatic artery infusion: a review of 4580 reported cases. Int J Gastrointest Cancer 2001;30:147-160.